0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Intravenous Cholecystography with Cholografin in Infants

THOMAS E. REICHELDERFER, M.D.; JOYCE VAN HARTESVELDT, R.T.
AMA Am J Dis Child. 1955;89(5):591-595. doi:10.1001/archpedi.1955.02050110705011.
Text Size: A A A
Published online

This paper reports the use of Cholografin (disodium salt of N,N'-adipyl-bis-[3-amino-2,4,6-triiodo]-benzoic acid) for visualization of the gall bladder in infancy. Cholecystography has been difficult and unsatisfactory in this age group. These preliminary studies are presented because Cholografin appears to be superior to any of the contrast materials previously used for this purpose in the early months of life.

Cholografin is identical with Biligrafin of Schering, A. G., and has been subjected to clinical trials in Germany which were reported in 1953.* Cholografin is a crystalline powder readily soluble to about 20% in water to give a colorless isotonic solution. It has a higher iodine content than other comparable contrast media. Cholografin is given intravenously and is excreted by the liver, the first traces appearing in the bile within a few minutes. The extrahepatic ducts may be visualized in adults within 15 to 20 minutes following injection. Filling of the gall

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();